Table 3.
Cardiology Service (n=218) | Noncardiology Service (n=142) | Adjusted OR (95% CI)* | |
---|---|---|---|
Inhospital medication, % | |||
Aspirin use | 39 | 35 | 1.0 (0.4–2.6) |
Heparin use | 14 | 15 | 0.8 (0.4–1.7) |
β-Blocker use | 27 | 21 | 1.3 (0.5–3.1) |
Ca2+-channel blocker use | 5 | 4 | 1.6 (0.4–5.7) |
Diagnostic evaluation, % | |||
Noninvasive testing | 78 | 51 | 3.3 (2.0–5.2) |
Cardiac catheterization | 10 | 1 | 6.9 (1.0–47) |
Subsequent care, % | |||
ED revisit or readmission | 11 | 16 | 1.1 (0.6–2.1) |
Outpatient follow-up | 69 | 70 | 1.1 (0.7–1.8) |
Adjusted for propensity of being admitted to cardiology, comorbidity score, predicted probability of acute cardiac ischemia, and intervention period. Reference group is noncardiology patients.